Stay updated on ARO-APOC3 in FCS Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.

Latest updates to the ARO-APOC3 in FCS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedResults for the PALISADE study were posted on 2026-02-04, and the study overview was expanded to include the trial’s purpose, design, and open-label extension details.SummaryDifference6%

- Check21 days agoChange DetectedA site-wide notice about government funding lapse and NIH Clinical Center status was added, and the page shows a version update from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a Show glossary option and updated metadata to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Capitalization and wording changes were made to labels such as No FEAR Act data.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no user-visible content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded multiple study locations across the US and international sites (e.g., Florida, Georgia, Indiana, Maryland, Missouri, New York, Texas, Virginia, New South Wales, Victoria, Ontario, Quebec, Cedez 05, Mexico DF, Morelos, Kayseri) and introduced a 'Results Submitted' status. Several existing locations were removed, and the page version updated to v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page; no study content or core details were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.